INphoton provides quantitative, intravital molecular imaging at subcellular resolution, data analysis and consultation, resulting in a cost-effective approach to accelerate preclinical drug development. State-of-the-art multiphoton microscopy combined with novel surgical techniques and multiple fluorophores allow imaging the internal organs and tissues of living rodents at subcellular resolution.
These innovative high-content imaging technologies provide quantitative organ, cellular and subcellular distribution of potential therapeutic compounds as well as pharmacokinetics, pharmacodynamics and toxicity data. INphoton's clients have found that the unique insights provided by in vivo multiphoton microscopy significantly expedite the process of preclinical drug evaluation.